What's in Brigitte Schürch's pipeline?

Brigitte Schürch has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Brigitte Schürch's portfolio?

Top competitors by shared drug class: ATGC Co., Ltd., Assistance Publique - Hôpitaux de Paris, Carruthers Dermatology Centre, Department of Medical Services Ministry of Public Health of Thailand, Galderma R&D.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/brigitte-sch-rch.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Brigitte Schürch — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Brigitte Schürch pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Botox 100 UNT Injection	Botox 100 UNT Injection	marketed	Botulinum toxin type A	SNAP-25 (synaptosome-associated protein of 25 kDa)	Neurology, Dermatology, Aesthetics

Therapeutic area mix

Neurology, Dermatology, Aesthetics · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ATGC Co., Ltd. · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Carruthers Dermatology Centre · 1 shared drug class
Department of Medical Services Ministry of Public Health of Thailand · 1 shared drug class
Galderma R&D · 1 shared drug class
Huons Co., Ltd. · 1 shared drug class
Innovaderm Research Inc. · 1 shared drug class
Lupo Center for Aesthetic and General Dermatology · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Brigitte Schürch:

Cite this brief

Drug Landscape (2026). Brigitte Schürch — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/brigitte-sch-rch. Accessed 2026-06-10.